| 2020 | Inhibition of SARS-CoV-2 by Highly Potent Broad-Spectrum Anti-Coronaviral Tylophorine-Based Derivatives | Yang, Cheng-Wei; Lee, Yue-Zhi; Hsu, Hsing-Yu; Jan, Jia-Tsrong; Lin, Yi-Ling ; Chang, Sui-Yuan; Peng, Tzu-Ting; Yang, Ruey-Bing ; Liang, Jian-Jong; Liao, Chun-Che ; Chao, Tai-Ling; Pang, Yu-Hau; Kao, Han-Chieh; Huang, Wen-Zheng; Lin, Jiunn-Horng; Chang, Chun-Ping; Niu, Guang-Hao; Wu, Szu-Huei; Sytwu, Huey-Kang; Chen, Chiung-Tong; Lee, Shiow-Ju | Frontiers in Pharmacology 11, 606097 | | | |
| 2022 | The Synergistic Inhibition of Coronavirus Replication and Induced Cytokine Production by Ciclesonide and the Tylophorine-Based Compound Dbq33b | Lee, Yue-Zhi; Hsu, Hsing-Yu; Yang, Cheng-Wei; Lin, Yi-Ling ; Chang, Sui-Yuan; Yang, Ruey-Bing ; Liang, Jian-Jong; Chao, Tai-Ling; Liao, Chun-Che ; Kao, Han-Chieh; Chang, Jang-Yang; Sytwu, Huey-Kang; Chen, Chiung-Tong; Lee, Shiow-Ju | Pharmaceutics 14(7), 1511 | | | |
